Neural tube defects: risk factors and prevention
DOI:
https://doi.org/10.15584/ejcem.2017.2.9Keywords:
neural tube defects, NTD, anencephaly, spina bifidaAbstract
Neural tube defects are abnormalities that can occur in the brain (anencephaly, encephalocele), spine (spina bifida, myelomeningocele, myelodysplasia), both brain and spine (craniorachischisis) or spinal column of a developing embryo that are present at birth. They arise when the neural tube, the embryonic precursor of the brain and spinal cord, fails to close during neurulation. Many cases of neural tube defects occur worldwide each year in more than 300,000 newborn babies and are a significant cause of infant death and lifelong disability. Most neural tube defects are preventable. The prevalence of these abnormalities has decreased in the past 20 to 30 years due to periconceptional folate supplementation, food fortification and decreased exposure to environmental factors. Women who are planning to conceive should be informed about the importance of folic acid in fetal development and encouraged to take 400 μg/day of folic acid supplements. Numerous research studies have shown that taking this dosage of folic acid before and during early pregnancy significantly reduces the risk of neural tube defects. For that reason it is important to increase the awareness of women in childbearing age about the necessity of primary prevention and folate intake which is a strong factor that has wide implications in public health in reducing the mortality and morbidity of offspring.Downloads
References
Khoshnood B, Loane M, de Walle H, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. The BMJ. 2015;351.
Yamaguchi Y, Miyazawa H, Miura M. Neural tube closure and embryonic metabolism: Neural tube closure and metabolism. Congenit Anom. 2017. doi:10.1111/cga.12219.
Sadler TW. Mechanisms of neural tube closure and defects. Ment Retard Dev Disabil Res Rev. 1998;4(4):247–253.
Sasai Y, De Robertis EM. Ectodermal Patterning in Vertebrate Embryos. Dev Biol. 1997;182(1):5-20.
Araya C, Carmona-Fontaine C, Clarke JDW. Extracellular matrix couples the convergence movements of mesoderm and neural plate during the early stages of neurulation. Dev Dyn Off Publ Am Assoc Anat. 2016;245(5):580-589.
Greene NDE, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet. 2009;18(R2):R113-129.
Kamen B. Folate and antifolate pharmacology. Semin Oncol. 1997;24,5(18):18-39.
Figueiredo JC, Grau MV, Haile RW, et al. Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial. JNCI J Natl Cancer Inst. 2009;101(6):432-435.
Berry RJ, Li Z, Erickson JD, et al. Prevention of Neural-Tube Defects with Folic Acid in China. N Engl J Med. 1999;341(20):1485-1490.
Czeizel AE, Dud?s I. Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation. N Engl J Med. 1992;327(26):1832-1835.
Hibbard BM. The role of folic acid in pregnancy, with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw. 1964;71:529-542.
van Straaten HW, Copp AJ. Curly tail: a 50-year history of the mouse spina bifida model. Anat Embryol (Berl). 2001;203(4):225-237.
Greene NDE, Leung K-Y, Gay V, et al. Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. Br J Nutr. 2016;115(6):974-983.
Cavalli P, Tonni G, Grosso E, Poggiani C. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. Birt Defects Res A Clin Mol Teratol. 2011;91(11):962-965.
Pai YJ, Leung K-Y, Savery D, et al. Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice. Nat Commun. 2015;6:6388.
Vieira AR, Castillo Taucher S. Influence of maternal age on the risk for neural tube defects, a meta analysis. Rev Médica Chile. 2005;133(1):62-70.
Brough L, Rees GA, Crawford MA, Dorman EK. Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status. J Hum Nutr Diet. 2009;22(2):100-107.
Smith K, Freeman KA, Neville-Jan A, Mizokawa S, Adams E. Cultural Considerations in the Care of Children with Spina Bifida. Pediatr Clin North Am. 2010;57(4):1027-1040.
Brender JD, Felkner M, Suarez L, Canfield MA, Henry JP. Maternal Pesticide Exposure and Neural Tube Defects in Mexican Americans. Ann Epidemiol. 2010;20(1):16-22.
Gonzalez-Herrera L, Martin Cerda-Flores R, Luna-Rivero M, et al. Paraoxonase 1 polymorphisms and haplotypes and the risk for having offspring affected with spina bifida in Southeast Mexico. Birt Defects Res A Clin Mol Teratol. 2010;88(11):987-994.
Herdt-Losavio ML, Lin S, Chapman BR, et al. Maternal occupation and the risk of birth defects: an overview from the National Birth Defects Prevention Study. Occup Environ Med. 2010;67(1):58-66.
Suarez L, Felkner M, Hendricks K. The effect of fever, febrile illnesses, and heat exposures on the risk of neural tube defects in a Texas-Mexico border population. Birt Defects Res A Clin Mol Teratol. 2004;70(10):815-819.
Muñoz JB, Lacasaña M, Aburto VHB, Sánchez LET, García AMG, Carrillo LL. Socioeconomic Factors and the Risk of Anencephaly in a Mexican Population: A Case-Control Study. Public Health Rep. 2005;120(1):39-45.
Hosako H, Francisco LE, Martin GS, Mirkes PE. The roles of p53 and p21 in normal development and hyperthermia-induced malformations. Birth Defects Res B Dev Reprod Toxicol. 2009;86(1):40-47.
MJ E. Prenatal loss of foetuses and abortion in guinea-pigs. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/?term=Edwards+MJ.+1966.+Prenatal+loss+of+foetuses+and+abortion+in+guinea-pigs.+Nature+210%3A223%E2%80%932. Accessed June 18, 2017.
Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal Hyperthermia and the Risk for Neural Tube Defects in Offspring: Systematic Review and Meta-Analysis. Epidemiology. 2005;16(2):216-219.
Edwards MJ, Saunders RD, Shiota K. Effects of heat on embryos and foetuses. Int J Hyperthermia. 2003;19(3):295-324.
Kline J, Stein Z, Susser M, Warburton D. Fever during pregnancy and spontaneous abortion. Am J Epidemiol. 1985;121(6):832-842.
Little SA, Kim WK, Mirkes PE. Teratogen-induced activation of caspase-6 and caspase-7 in early postimplantation mouse embryos. Cell Biol Toxicol. 2003;19(4):215-226.
Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ. 2006;13(6):1027-1036.
Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci. 2004;25(4):177-181.
Martínez-Frías ML, García Mazario MJ, Caldas CF, Conejero Gallego MP, Bermejo E, Rodríguez-Pinilla E. High maternal fever during gestation and severe congenital limb disruptions. Am J Med Genet. 2001;98(2):201-203.
Feldkamp ML, Meyer RE, Krikov S, Botto LD. Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol. 2010;115(1):109-115.
Russell RM, Golner BB, Krasinski SD, Sadowski JA, Suter PM, Braun CL. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid. J Lab Clin Med. 1988;112(4):458-463.
Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343(22):1608-1614.
Kondo A, Morota N, Ihara S, et al. Risk factors for the occurrence of spina bifida (a case-control study) and the prevalence rate of spina bifida in Japan: Risk Factors and Prevalence of Spina Bifida. Birt Defects Res A Clin Mol Teratol. 2013;97(9):610-615.
McDonald SD, Perkins SL, Jodouin CA, Walker MC. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am J Obstet Gynecol. 2002;187(3):620-625.
Gao L-J, Wang Z-P, Lu Q-B, Gong R, Sun X-H, Zhao Z-T. Maternal overweight and obesity and the risk of neural tube defects: a case-control study in China. Birt Defects Res A Clin Mol Teratol. 2013;97(3):161-165.
Dietl J. Maternal obesity and complications during pregnancy. J Perinat Med. 2005;33(2).
Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85(1):1-9.
Hendricks KA, Nuno OM, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiol Camb Mass. 2001;12(6):630-635.
Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom. 2006;46(2):55-67.
Rothman KJ, Moore LL, Singer MR, Nguyen U-SDT, Mannino S, Milunsky A. Teratogenicity of High Vitamin A Intake. N Engl J Med. 1995;333(21):1369-1373.
Perez ABA, D’Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D. Methylenetetrahydrofolate reductase (MTHFR): incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet. 2003;119A(1):20-25.
Mohd-Zin SW, Marwan AI, Abou Chaar MK, Ahmad-Annuar A, Abdul-Aziz NM. Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans. Scientifica. 2017;2017:1-29.
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. The Lancet. 1991;338(8760):131-137.
Smith MA, Lau C. A resolution on folic acid fortification. Birt Defects Res A Clin Mol Teratol. 2015;103(1):1-2.
Odewole OA, Williamson RS, Zakai NA, et al. Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for Geographic and Racial Differences in Stroke study 2003-2007. Am J Clin Nutr. 2013;98(4):1042-1047.
Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep. 2004;53(17):362-365.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
